On July 28, 2022, Concord IP2 Ltd requested the Pasithea Therapeutics Corp to call a special meeting of the shareholders and made 2 books and records demands to receive additional information regarding the Company and investigate potential actions by the board. In addition, Concord IP2 Ltd submitted a nomination notice to the Company nominating David Delaney, Avi Geller and Eric Shahinian to the Company board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.46 USD | -0.91% | -14.69% | -26.22% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.22% | 61.03L | |
+11.91% | 11TCr | |
+11.60% | 10TCr | |
-4.68% | 2.38TCr | |
-0.82% | 2.17TCr | |
-10.12% | 1.81TCr | |
-42.12% | 1.63TCr | |
-17.47% | 1.61TCr | |
+2.77% | 1.38TCr | |
+34.58% | 1.18TCr |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Concord IP2 Ltd Nominates Candidates to the Board of Pasithea Therapeutics Corp